Literature DB >> 23599454

Biomedicine. Rare cancer successes spawn 'exceptional' research efforts.

Jocelyn Kaiser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23599454     DOI: 10.1126/science.340.6130.263

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  Src inhibition is still a relevant target in pancreatic cancer.

Authors:  Thomas J George; Jose G Trevino; Chen Liu
Journal:  Oncologist       Date:  2014-01-23

Review 2.  Rapid learning for precision oncology.

Authors:  Jeff Shrager; Jay M Tenenbaum
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

Review 3.  Beyond histology: translating tumor genotypes into clinically effective targeted therapies.

Authors:  Catherine B Meador; Christine M Micheel; Mia A Levy; Christine M Lovly; Leora Horn; Jeremy L Warner; Douglas B Johnson; Zhongming Zhao; Ingrid A Anderson; Jeffrey A Sosman; Cindy L Vnencak-Jones; Kimberly B Dahlman; William Pao
Journal:  Clin Cancer Res       Date:  2014-03-05       Impact factor: 12.531

4.  Long-term survival in a case of metastatic papillary renal cell carcinoma.

Authors:  Abdul Monem Essam; Ajit Venniyoor; Suresh Nagdev; Itrat Mehdi; Bassim Al Bahrani
Journal:  South Asian J Cancer       Date:  2017 Jan-Mar

5.  Towards personalized tumor markers.

Authors:  Vathany Kulasingam; Ioannis Prassas; Eleftherios P Diamandis
Journal:  NPJ Precis Oncol       Date:  2017-05-25

6.  Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2.

Authors:  Ralf Kleef; Ralph Moss; A Marcell Szasz; Arthur Bohdjalian; Hans Bojar; Tibor Bakacs
Journal:  Integr Cancer Ther       Date:  2018-09-07       Impact factor: 3.279

7.  Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs.

Authors:  Tibor Bakacs; Rifaat Safadi; Imre Kovesdi
Journal:  Hepatol Med Policy       Date:  2018-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.